CDK4/ 6抑制は抗腫瘍免疫を誘発する
Shom Goel1,2, Molly J DeCristo3,4, April C Watt1
1Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Nature
|August 17, 2017
まとめ
選択的なCDK4/ 6阻害剤は,腫瘍細胞のサイクルを停止するだけでなく,免疫性を高め,T細胞の反応を強める. これはがん治療の新しい組み合わせの治療法を示唆しています.
科学分野:
- 腫瘍学
- 免疫学
- 分子生物学
背景:
- サイクリン依存キナーゼ4と6 (CDK4/6) は,様々な癌に関与する重要な細胞循環調節体である.
- CDK4/ 6阻害剤は,主に細胞サイクル停止を誘導することによって,いくつかの固体腫瘍の治療法として確立されています.
研究 の 目的:
- 選択的CDK4/ 6阻害剤が抗腫瘍免疫に与える影響を調査する.
- CDK4/ 6阻害剤による免疫強化の基礎となるメカニズムを解明する.
- CDK4/ 6阻害剤と免疫療法の組み合わせの可能性を調査する.
主な方法:
- 乳がんやその他の固体腫瘍のマウスモデルを使用した.
- 乳がんの臨床試験の シリアルバイオプシのトランスクリプトミア分析
- 腫瘍細胞,調節性T細胞,免疫反応への影響を調査した.
主要な成果:
- CDK4/ 6阻害剤は腫瘍細胞サイクル停止を誘導し,抗腫瘍免疫を促進する.
- 阻害剤は内在的なレトロウイルス要素を活性化し,III型インターフェロンを増やし,抗原表現を高めます.
- CDK4/ 6阻害剤は,減少したDNAメチルトランスフェラーゼ1活性によって調節性T細胞増殖を抑制する.
- これらの効果は細胞毒性T細胞のクリアランスを促進し,免疫チェックポイントのブロックによりさらに強化されます.
結論:
- CDK4/ 6阻害剤は腫瘍の免疫原性を増加させる.
- 抗がん治療の強化のためのCDK4/ 6阻害剤と免疫療法の新しい組み合わせを裏付けています.
関連する概念動画
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:15M-Cdk Drives Transition Into Mitosis
6.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
02:39Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K